Effectiveness of Pfizer-BioNTech’s BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron variants among teens - News-Medical.Net

6/30/2022 12:00:00 AM2 years 10 months ago

Researchers evaluated Pfizer-BioNTech’s BNT162b2 vaccine effectiveness after two and three doses against SARS-CoV-2 variants of concern such as Delta and in Canadian adolescent community residents.

In a recent study posted to the medRxiv* preprint server, researchers evaluated Pfizer-BioNTech’s BNT162b2 vaccine effectiveness (VE) after two and three doses against severe acute respiratory syndro… [+6187 chars]

full article...